Navigation : home Accueil du site > DPC Dialyse > 36 Solutions en dialyse péritonéale

36 Solutions en dialyse péritonéale

Mise à jour : 0000 - Mise en ligne : 17 mai 2025, par Thierry Hannedouche
 
Notez cet article :
0 vote

 
Impression & PDF

1 - Diaporama


2 - Vidéo


3 - QCM d’évaluation

 
 

Références

Brown EA, Blake PG, Boudville N, et al. International Society for Peritoneal Dialysis practice recommendations : Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020 ;896860819895364. 32063219

Figueiredo AE, Bernardini J, Bowes E, et al. A Syllabus for Teaching Peritoneal Dialysis to Patients and Caregivers. Perit Dial Int. 2016 ;36(6):592–605. 26917664

Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT ; Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002 Feb ;13(2):470-9. 11805177

Li YC, Sung PH, Yang YH, Chiang JY, Yip HK, Yang CC. Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis. Commun Biol. 2021 Jan 29 ;4(1):144. 33514826

Piccapane F, Bonomini M, Castellano G, Gerbino A, Carmosino M, Svelto M, Arduini A, Procino G. A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells. Int J Mol Sci. 2020 Dec 24 ;22(1):123. 33374405

van Diepen ATN, Coester AM, Janmaat CJ, Dekker FW, Struijk DG, Krediet RT. Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility. Kidney Int Rep. 2020 Oct 10 ;5(12):2183-2194. 33305111

Holmes CJ, Shockley TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000 ;20 Suppl 2:S37-41. 10911641

Holmes CJ. Reducing cardiometabolic risk in peritoneal dialysis patients : role of the dialysis solution. J Diabetes Sci Technol. 2009 Nov 1 ;3(6):1472-80. 20144403

Posthuma N, ter Weel PM, Donker AJ, Peers EM, Oe PL, Verbrugh HA. Icodextrin use in CCPD patients during peritonitis : ultrafiltration and serum disaccharide concentrations. Nephrol Dial Transplant. 1998 Sep ;13(9):2341-4. 9761519

Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R ; behalf of the DIUREST Study Group. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients : a prospective randomized study. Nephrol Dial Transplant. 2010 Jul ;25(7):2288-96. 20197284

Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi Y ; Japanese Extraneal Collaborated Study Group. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol. 2007 ;27(4):409-15. 17622748

Rutkowski B, Tam P, van der Sande FM, Vychytil A, Schwenger V, Himmele R, Gauly A ; Low Sodium Balance Study Group. Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients : A Randomized Controlled Trial. Am J Kidney Dis. 2016 May ;67(5):753-61. 26388284